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Abstract
Background: Concurrent use of marijuana and alcohol in drivers is of increasing concern but its role in crash
causation has not been well understood.
Methods: Using a case–control design, we assessed the individual and joint effects of marijuana and alcohol use
on fatal crash risk. Cases (n = 1944) were drivers fatally injured in motor vehicle crashes in the United States at
specific times in 2006, 2007 and 2008. Controls (n = 7719) were drivers who participated in the 2007 National
Roadside Survey of Alcohol and Drug Use by Drivers.
Results: Overall, cases were significantly more likely than controls to test positive for marijuana (12.2% vs. 5.
9%, p < 0.0001), alcohol (57.8% vs. 7.7%, p < 0.0001) and both marijuana and alcohol (8.9% vs. 0.8%, p < 0.0001).
Compared to drivers testing negative for alcohol and marijuana, the adjusted odds ratios of fatal crash
involvement were 16.33 [95% confidence interval (CI): 14.23, 18.75] for those testing positive for alcohol and
negative for marijuana, 1.54 (95% CI: 1.16, 2.03) for those testing positive for marijuana and negative for
alcohol, and 25.09 (95% CI: 17.97, 35.03) for those testing positive for both alcohol and marijuana.
Conclusions: Alcohol use and marijuana use are each associated with significantly increased risks of fatal
crash involvement. When alcohol and marijuana are used together, there exists a positive synergistic effect on
fatal crash risk on the additive scale.
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Background
Driving under the influence of drugs (DUID) is a serious
public safety concern in the United States and around
the world (Brady & Li 2013; Romano & Voas 2011;
Kaplan et al. 2006; Berning et al. 2015; Hartman &
Huestis 2013; Walsh et al. 2005; Dubois et al. 2015).
About one third of fatally injured drivers in the United
States tested positive for nonalcohol drugs and 20%
tested positive for two or more drugs (Brady & Li 2013;
Romano & Voas 2011; Kaplan et al. 2006). The prevalence
of non-alcohol drugs in weekend nighttime drivers is about
20% (Berning et al. 2015). Marijuana is the most frequently
detected nonalcohol drug and the concurrent use of
marijuana and alcohol is the most frequently detected poly-
drug combination in the general driver population (Berning
et al. 2015) and in fatally injured drivers (Walsh et al. 2005;
Dubois et al. 2015; Li et al. 2013). Over the past decade,
traffic fatalities involving nonalcohol drugs have increased
markedly while fatalities involving alcohol have remained
fairly stable (Brady & Li 2013; Li et al. 2013; Brady & Li
2014). Specifically, the prevalence of marijuana positivity in
fatally injured drivers had tripled from 4% in 1999 to 12%
in 2010 (Brady & Li 2014). Evidence from experimental
studies has shown that marijuana impairs almost every as-
pect of performance associated with safe driving (Lenné et
al. 2010; Bosker et al. 2012; Downey et al. 2013; Hartman et
al. 2015) and recent epidemiologic studies have found that
marijuana use may double the risk of car crash involvement
(Li et al. 2012, Asbridge et al. 2012).
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Since 1996, 28 states and Washington, DC have
enacted legislation to decriminalize marijuana for med-
ical use (NCSL 2016). Of these states, eight have further
decriminalized possession of small amounts of marijuana
for adult recreational use (NCSL 2016). Colorado has
registered an increase in fatal motor vehicle crashes in-
volving marijuana since legalizing marijuana for medical
use in 2000 (Urfer et al. 2014) compared to insignificant
changes in states without medical marijuana laws
(Salomonsen-sautel et al. 2014).
Young adults may be at a particularly high risk from
the increased availability and potency of marijuana
(Brady & Li 2013; Cerda et al. 2012; Lynne-Landsman et
al. 2013; Harper et al. 2012; Wall et al. 2011; O’Malley &
Johnston 2007). Given the increasing prevalence of
DUID (Brady & Li 2013; Berning et al. 2015; Dubois et
al. 2015; Brady & Li 2014) and the increasing permissi-
bility and accessibility of marijuana (NCSL 2016), it is
urgent to better understand the role of marijuana and its
interaction with alcohol in motor vehicle crashes. Previ-
ous research on the interaction between alcohol and
marijuana has reported conflicting results, with some in-
dicating the interaction effect to be possibly synergistic
(i.e., the combined effect is more than the sum of the
net effects of marijuana and alcohol) (Bates & Blakely
1999; Brault et al. 2004; Biecheler et al. 2008; Ramaekers
et al. 2000; Ramaekers et al. 2004; Sewell et al. 2009; Sutton
1983; Perez-Reyes et al. 1988) or additive (i.e., the com-
bined effect is equal to the sum of the net effects of
marijuana and alcohol) (Ramaekers et al. 2004; Sewell et
al. 2009; Bramness et al. 2010; Drummer et al. 2004;
Chesher 1986; Kelly et al. 2004) and others suggesting no
additive effect (Lamers & Ramaekers 2001; Liguori et al.
2002). Understanding the role of marijuana and its inter-
action with alcohol in motor vehicle crashes is important
in order to develop targeted, effective public health inter-
ventions and prudent use of resources in mitigating the
rising prevalence of DUID. In the present study, we use a
population-based case–control study design and data
from two national surveillance systems to assess the indi-
vidual and joint effects of marijuana and alcohol use on
the risk of fatal crash involvement.
Methods
Data sources
Data for this study came from two sources: 1) the Fatality
Analysis Reporting System (FARS) and 2) the 2007 Na-
tional Roadside Survey of Alcohol and Drug Use by
Drivers (NRS). Both data systems are sponsored and
maintained by the National Highway Traffic Safety
Administration (Washington, DC). The FARS is a census
of all crashes that occur on public roads in the United
States and result in at least one death of an occupant or
non-occupant within 30 days of the crash (National
Highway Traffic Safety Administration 2012). This data re-
pository includes detailed information on the people and
vehicles involved as well as circumstances of the crash.
Data elements include driver characteristics (e.g., age, sex,
survival status, drug and alcohol test results, driving his-
tory within the past 3 years), vehicle characteristics (e.g.,
model, make, type, year, weight rating) and crash circum-
stances (e.g., date, time, light and atmospheric conditions)
(National Highway Traffic Safety Administration 2012).
Data are obtained from various state documents such as
police accident reports, death certificates, coroner/medical
examiner reports, state vehicle registration files, hospital
medical reports and vital statistics (National Highway
Traffic Safety Administration 2012). To ensure accuracy
and completeness, several programs continuously monitor
the data and each entry is automatically checked for ac-
ceptable range and consistency. Toxicological testing re-
sults for nonalcohol drugs are available for only about
one-third of fatally injured drivers nationwide due to in-
complete testing and reporting (NHTSA 2010, 2012).
However, 12 states performed drug testing on more than
80% of fatally injured drivers during the study period.
The 2007 NRS was a national field survey based on vol-
untary and anonymous random stops of non-commercial
drivers at 300 locations across the contiguous United
States (Lacey et al. 2009). The sample was selected using a
multistage random sampling method that include four
levels; primary sampling units, police jurisdictions, survey
locations and passing-by drivers (Lacey et al. 2009).
Drivers at the designated study locations were randomly
stopped and invited to participate in the survey. Verbally
consented drivers responded to questions about their trip
origin, destination, demographics, mileage and drinking
behavior and provided an oral fluid sample for drug test-
ing as well as a breath sample for alcohol testing. The
2007 NRS was conducted between 10 PM and midnight
and 1 AM to 3 AM on Fridays and Saturdays and
9:30 AM to 11:30 AM and 1:30 PM to 3:30 PM on Fridays
during July 20 through December 1, 2007. The overall re-
sponse rate for the 2007 NRS was 70.7% (Lacey et al.
2009). For each driver, the final overall sampling probabil-
ity was equivalent to the product of sampling probabilities
at each of the four levels of sampling. The final sampling
weight was computed as the inverse of the overall sam-
pling probability, i.e., data from drivers who were unlikely
to be interviewed based on the sampling procedure used
were given more weight than data from drivers who were
more likely to be interviewed (Lacey et al. 2009). Add-
itional details of the sampling method and study protocol
are described elsewhere (Lacey et al. 2009).
Study design and study subjects
A population-based case–control design was used to as-
sess the role of marijuana and the interaction effect of
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marijuana and alcohol on the risk of fatal crash involve-
ment. Of the 3735 drivers in the sample, 1605 (42.9%)
were excluded from the study due to missing drug test-
ing results and 186 (4.9%) cases from Maryland, New
Mexico and North Carolina were excluded because of
concerns about the accuracy and reliability of drug test-
ing data recorded in the FARS for these states (NHTSA
2012; SAMHSA 2010). Cases (n = 1944) were drivers
with available drug testing results in the FARS who were
involved in crashes at the same time of day and the same
day of week as controls were interviewed (i.e., between
10 PM and midnight and 1 AM to 3 AM on Fridays and
Saturdays and 9:30 AM to 11:30 AM and 1:30 PM to
3:30 PM on Fridays during July 20 through December 1
in 2006, 2007 and 2008 in the continental United States).
Controls (n = 7719) were drivers with available drug test-
ing results from oral fluid samples in the 2007 NRS. This
study was deemed exempt from review under 45 CFR 46
by the Columbia University Medical Center Institutional
Review Board (New York, NY).
Drug testing assessments
Drug tests for cases were performed on blood and/or
urine specimens using radioimmunoassay techniques
and liquid/gas chromatography coupled with mass spec-
tometry (Kaplan et al. 2006; Li et al. 2011). Overall, 1759
(90.5%) of the 1944 cases included in the analysis had at
least one drug test based on blood specimens. For each
case, the FARS records the presence of up to three non-
alcohol drugs (Kaplan et al. 2006; National Highway
Traffic Safety Administration 2012). In the presence of
multiple drugs, nonalcohol drugs are recorded in the
following order: narcotics, depressants, stimulants,
marijuana and other illicit drugs including phencyclid-
ine, anabolic steroid, inhalant and medications (Kaplan et
al. 2006; National Highway Traffic Safety Administration
2012). If a drug and its metabolite were detected, only the
parent drug was recorded. Cannabinoids was the drug
class for marijuana products such as hashish, pot or weed
(National Highway Traffic Safety Administration 2012).
Blood alcohol concentrations (BACs) were recorded sep-
arately from nonalcohol drugs. Drug tests for controls
were performed on oral fluid samples that were screened
using enzyme-linked immunosorbent assay and then con-
firmed using liquid/gas chromatography–mass spectrom-
etry (National Highway Traffic Safety Administration
2012). BACs for controls were determined from breath
samples measured using a preliminary breath test device
(National Highway Traffic Safety Administration 2012;
Lacey et al. 2009).
Statistical analysis
The associations of alcohol and marijuana use with the
risk of fatal crash involvement were measured by
estimated odds ratios (ORs) and 95% confidence inter-
vals (95% CIs) with drivers who tested negative as the
reference group. Crude ORs and 95% CIs were com-
puted for driver age, sex, marijuana testing result and
blood alcohol concentration. BAC was measured in
grams per deciliter and a value of 0.01 g/dL or greater
was considered positive. BAC was categorized into 3
levels; 0, 0.01–0.07 and ≥0.08 g/dL according to current
per se laws in the United States. Separate and joint ef-
fects of marijuana and BAC levels were assessed, with
drivers testing negative for marijuana and alcohol as the
reference group. Interaction of marijuana and alcohol
was first examined as a departure from multiplicativity,
i.e., whether the joint effect of alcohol and marijuana dif-
fers from the multiplicative model expected on the basis
of their separate net effects adjusting for demographic
variables. To assess the presence, magnitude and direc-
tion of interaction on the multiplicative scale, the esti-
mated adjusted odds ratios from the logistic regression
models were substituted into the following equation
(Rothman 1986; VanderWeele 2014):
ORmarijuanaþalcohol= ORmarijuana
   ORalcoholð Þ
 
where a value >1 implies presence of positive interaction,
a value < 1 implies presence of negative interaction and a
value of 1 implies absence of interaction. Interaction was
also tested as a departure from additivity, i.e., whether
the joint effects of alcohol and marijuana were in excess
of the sum of their individual effects. Additive inter-
action was assessed based on three measures; the relative
excess risk due to interaction (RERI), the attributable
proportion due to interaction (API) and the synergy
index (S) as shown below (Rothman 1986; Knol et al.
2012; VanderWeele & Knol 2014; Andersson et al.
2005):
RERI ¼ ORmarijuanaþalcohol–ORmarijuana– ORalcohol þ 1
API ¼ RERI=ORmarijuanaþalcohol
S ¼ ORmarijuanaþalcohol–1= ORmarijuana–1
  þ ORalcohol–1ð Þ
 
where RERI = 0, API = 1 and S = 1 denotes absence of
interaction. Estimates for RERI and 95% CI from the
delta method were computed using an approach sug-
gested by VanderWeele and Knol (VanderWeele & Knol
2014). Lastly, we assessed marijuana as an effect modi-
fier (VanderWeele 2009), i.e., whether the effect of BAC
on the risk of crash involvement was homogenous be-
tween marijuana positive and negative drivers. The
Tarone adjusted Breslow Day test (Breslow & Day
1980; Tarone 1985) was used to assess homogeneity
between marijuana strata. To ensure that our findings
were robust, we performed three separate sensitivity
analyses: first, by including only cases from the 12
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states that tested more than 80% of fatally injured
drivers during the study period; second, by analyzing
weighted data accounting for the complex sampling
design among controls (Lacey et al. 2009); and third,
by conducting multiple imputation for missing marijuana
testing results among cases to assess the potential bias
from the missing marijuana data. The missing marijuana
testing data were imputed using a logistic regression
model with covariates including age, sex, license status,
previous incidents, year, day and time of crash, use of re-
straint, police reported drug use, vehicle role in the crash,
and region. Ten imputations were generated. All analyses
were performed using SAS 9.4 (SAS Institute Inc., Cary,
NC). The multiple imputation was performed using the
SAS callable software IVEware (Survey Research Center,
Institute for Social Research, University of Michigan, Ann
Arbor, MI).
Results
Compared to the excluded drivers, those included as
cases (n = 1944) were younger (mean age =36.8 (stand-
ard deviation, 16.8) years vs. 40.1 (standard deviation,
19.7) years), more likely to be involved in nighttime
crashes (70.1% vs. 63.3%, P < 0.0001), more likely to be
male (82.8% vs. 76.9%, P < 0.0001), and more likely to be
involved in a crash in the previous 3 years (12.8% vs.
11.0%, P = 0.01).
Overall, 12.2% of the 1944 cases and 5.9% of the 7719
controls tested positive for marijuana, yielding a crude
OR of 2.21 (95% CI: 1.87, 2.60). Positive BACs (BAC ≥
0.01 g/dL) were present in 57.8% of cases and 7.7% of
controls, yielding a crude OR of 16.42 (95% CI: 14.52,
18.57). As expected, the risk of fatal crash involvement
increased with BAC levels from a crude OR of 2.65
(95% CI: 2.16, 3.25) for 0.01–0.07 g/dL to 63.14
(95% CI: 52.01, 76.65) for ≥0.08 g/dl (Table 1). Male
drivers and drivers aged 16–39 years as well as those
aged 65 years and older were at significantly increased
risk of fatal crash involvement (Table 1).
Relative to drivers who tested negative for both alcohol
and marijuana, the estimated odds of fatal crash involve-
ment increased 16 fold for those testing positive for al-
cohol and negative for marijuana, 1.5 fold for those
testing negative for alcohol and positive for marijuana
positive, and over 25 fold for those testing positive for
both alcohol and marijuana (Table 2).
The joint odds ratio of marijuana at each BAC level
(OR0.01–0.07g/dL = 4.38; OR≥0.08g/dL =95.26) was equivalent
to the product of the individual marijuana and alcohol
odds ratios at each BAC level (OR0.01–0.07g/dL = 1.56*2.81;
OR≥0.08g/dL =1.56*61.11), indicating the absence of inter-
action on the multiplicative scale (Table 3). However, sig-
nificant interaction was present on the additive scale for
combined BAC levels (RERI = 2.94, 95% CI: 0.60, 5.28)
and for the separate BAC levels [(RERI0.07g/dL =1.01, RE-
RI≥0.08g/dL = 32.59), (API0.07g/Dl = 0.23, API≥0.08g/dL =0.34),
(S≥0.08g/dL =1.43, S≥0.08g/dL = 1.55)].
The estimated odds ratios of fatal crash involvement
increased with BAC level in similar degrees between
drivers testing positive for marijuana and those testing
negative for marijuana (Table 4) and there was no sig-
nificant heterogeneity in the estimated odds ratios asso-
ciated with BAC level between the marijuana strata
(Breslow Day Chi-square = 2.49, p = 0.288). Estimated
odds ratios from all three sensitivity analyses were con-
sistent with those derived from the actual drug testing
data (Appendix). Results from all sensitivity analyses
showed a significant positive interaction on the additive
scale [(RERI1 = 4.46 95% CI: 0.98, 7.95; RERI2 = 2.90 95%
CI: 0.60, 5.27; RERI3 = 2.77 95% CI: 2.11, 3.42)], but no
interaction on the multiplicative scale.
Discussion
Results of this study indicate that marijuana use is asso-
ciated with a significantly increased risk of involvement
in fatal motor vehicle crashes, as reported in recent epi-
demiological studies (Li et al. 2013; Li et al. 2012;
Asbridge et al. 2012). The combined effect of marijuana
and alcohol was greater than the sum of the net effects
of the two substances, which suggests that each
Table 1 Crude odds ratios and 95% confidence intervals of fatal
crash involvement according to driver age, sex, alcohol and
marijuana testing results in the continental United States,
selected time periods on Fridays and Saturdays, July 20 through
December 1, 2006, 2007 and 2008




Crude OR 95% CI
Age (years)
16–24 29.7 28.7 1.20 1.05, 1.36
25–39 33.2 32.0 1.20 1.06, 1.36
40–64 29.5 34.2 1.00
≥ 65 7.6 5.1 1.70 1.38, 2.10
Sex
Female 17.3 39.8 1.00
Male 82.7 60.2 3.16 2.79, 3.58
Blood alcohol concentration (g/dL)
0.00 42.2 92.3 1.00
0.01–0.07 7.2 5.9 2.65 2.16, 3.25
≥ 0.08 50.6 1.8 63.14 52.01, 76.65
Marijuana
Negative 87.8 94.1 1.00
Positive 12.2 5.9 2.21 1.87, 2.60
CI Confidence Interval, OR Odds Ratio
aThere were 23 cases with missing data on blood alcohol concentration
bThere were 93 controls with missing data on age, 21 controls with missing
data on sex and 7 controls with missing data on blood alcohol concentration
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substance plays a significant role in drivers’ involvement
in fatal motor vehicle crashes. All three measures (RERI,
API and S) confirmed the presence of significant positive
interaction between alcohol and marijuana on fatal crash
risk on the additive scale. Assuming positive monoton-
icity, i.e., both exposures (marijuana and alcohol) are
never protective, the positive additive interaction suffices
for mechanistic or sufficient cause interaction (Tarone
1985; VanderWeele & Robins 2007), which is indicative
of synergism. These findings are important because the
possible interaction between marijuana and alcohol on
driving safety has long been a cause of concern (Sutton
1983; Gjerde & Kinn 1991; Stramer & Bird 1984) and re-
cent toxicological data have shown that more that 20%
of drivers fatally injured in motor vehicle crashes test
positive for two or more drugs (Brady & Li 2013;
Romano & Voas 2011; Kaplan et al. 2006) with alcohol
and marijuana being the most common combination
(Brady & Li 2013; Walsh et al. 2005).
Our results are consistent with previous experimental
and epidemiological studies that have reported additive
effects of alcohol and marijuana on driving performance
and crash risk (Dubois et al. 2015; Bates & Blakely 1999;
Sewell et al. 2009; Doty et al. 1992; Belgrave et al. 1979;
Drummer et al. 2004; Chesher 1986) and possibly syner-
gistic (Brault et al. 2004; Biecheler et al. 2008; Sutton
1983; Perez-Reyes et al. 1988) effects. For instance, a
recent case–control study found that, relative to drivers
using neither alcohol nor marijuana, drivers who tested
positive for both alcohol (BAC ≤ 0.08 g/dL) and
marijuana had up to 128% increased odds of committing
an unsafe driver action compared to 16% for those using
marijuana alone and 117% for those using alcohol
(BAC ≤ 0.08 g/dL) alone (Dubois et al. 2015). Previous
studies that reported modest or no interaction between
marijuana and alcohol (Lamers & Ramaekers 2001;
Liguori et al. 2002) analyzed very small study samples
and assessed the effect of drugs on isolated experimental
dependent measures such as reaction time (Liguori et al.
2002) or visual search at intersections (Lamers &
Ramaekers 2001) instead of crash involvement in real
traffic situations. In addition to the large sample size,
this study was based on data from 46 states, including
10 out of 13 states that had legalized marijuana for med-
ical use as of 2008. Therefore, the findings of this study
could be considered more representative of the United
States than those reported in previous studies.
The present study provides valuable evidence for un-
derstanding the interaction of drugs and driving safety.
Many models in epidemiologic studies are inherently
multiplicative and tend to evaluate interaction on the
multiplicative scale only (Knol et al. 2009). This study
assessed interaction on both multiplicative and additive
scales. There has been debate in the epidemiologic
Table 2 Estimated odds ratios and 95% confidence intervals of fatal crash involvement according to driver alcohol and marijuana
testing results in the continental United States, selected time periods on Fridays and Saturdays, July 20 through December 1, 2006,
2007 and 2008
Testing Result
Marijuana Alcohol Crude OR 95% CI aAdjusted OR 95% CI
Negative Negative 1.00 Reference 1.00 Reference
Negative Positive 15.93 13.99, 18.14 16.33 14.23, 18.75
Positive Negative 1.46 1.11, 1.92 1.54 1.16, 2.03
Positive Positive 23.31 16.92, 32.12 25.09 17.97, 35.03
CI Confidence Interval, OR Odds Ratio
aAdjusted for age, sex and region
Table 3 Estimated odds ratios and 95% confidence intervals of fatal crash involvement according to driver BAC level and marijuana
testing results in the continental United States, selected time periods on Fridays and Saturdays, July 20 through December 1, 2006,
2007 and 2008
Testing Result
Marijuanal BAC leve Crude OR 95% CI aAdjusted OR 95% CI
Negative 0 1.00 Reference 1.00 Reference
Positive 0 1.46 1.11, 1.92 1.56 1.18, 2.06
Negative 0.01–0.07 2.72 2.20, 3.38 2.81 2.25, 3.50
Positive 0.01–0.07 3.99 2.77, 5.73 4.38 3.01, 6.37
Negative ≥0.08 59.73 48.72, 73.23 61.11 49.50, 75.46
Positive ≥0.08 87.42 61.18, 124.90 95.26 65.75, 138.02
BAC Blood Alcohol Content, g/dL, CI Confidence Interval OR Odds Ratio
aAdjusted for age, sex and region
Chihuri et al. Injury Epidemiology  (2017) 4:8 Page 5 of 9
literature as to which scale is better for assessing interac-
tions (Blot & Day 1979; Saracci 1980; Rothman et al.
1980). Some epidemiologists have pointed out the po-
tential limitations of using statistical interaction to
draw conclusions about biological interaction (Siemia-
tycki & Thomas 1981; Thompson 1991; Cordell 2002).
In this study, we assumed three sufficient causes of the
outcome (fatal crash involvement), with marijuana, al-
cohol and both marijuana and alcohol as the three dis-
parate causal mechanisms. Biological interaction was
assessed where both marijuana and alcohol are single
component causes in a combined causal mechanism.
The additive model underpins the methods for asses-
sing biological interaction (Rothman et al. 1980; Roth-
man 1976) and the notion of biological synergism
(Rothman 1976), which may be difficult to interpret
from multiplicative models. Although in some cases the
multiplicative scale may naturally correspond to inter-
action mechanisms (Siemiatycki & Thomas 1981), the
additive scale is of greater public health importance
(VanderWeele 2011) because it allows researchers to
discern the effect difference among subgroups.
The risk of fatal crash involvement associated with al-
cohol use appears to be homogenous between marijuana
strata, indicating that marijuana is not a significant effect
modifier in the BAC-fatal crash risk relationship. The
homogeneity test results corroborate the absence of
interaction on the multiplicative scale. At low doses,
marijuana and alcohol may be mostly associated with
impairment of low level operational driving skills
(Lamers & Ramaekers 2001; Liguori et al. 2002) with
gradual impairment of higher-level driving skills such as
hazard perception, risk management and self-control as
the doses increase. With the rising prevalence of
marijuana use, potency, social tolerance, early age of on-
set and availability (Brady & Li 2014; Cerda et al. 2012;
Lynne-Landsman et al. 2013; O’Malley & Johnston
2007), public health efforts should focus on strengthen-
ing and expanding drug testing as well as intervention
programs for drivers. Although it is illegal to drive under
the influence of alcohol and drugs in all states, almost
all of the one million registered medical marijuana users
are from states with older and less regulated programs
that have minimal physician or state oversight (Williams
et al. 2016). Therefore it is urgent to develop interven-
tion programs to reduce the unintended health conse-
quences of state laws legalizing marijuana for medical
and/or recreational use, such as injuries and fatalities
resulting from DUID.
This study has several notable limitations. First, drug
testing protocols vary from state to state (Asbridge
2014). Some states have low testing rates, which may
introduce selection bias. However, only subjects with
known drug testing results were included in this study
and results from the sensitivity analyses, including multi-
ply imputed drug testing results for excluded drivers,
were consistent with those from the actual testing data.
Second, there are additional possible causal components
for crash involvement that are not measured in the
study, such as driver’s health status, comorbidity, medi-
cation use and weather condition and other environ-
mental factors. Third, a positive test for marijuana
indicates marijuana use but not necessarily marijuana-
induced impairment as marijuana metabolites could re-
main in the blood for weeks after use (Voas et al. 2011;
Skopp & Potsch 2008). Finally, marijuana tests were
based on blood and urine specimens for cases and oral
fluids for controls. The oral fluid testing method is
widely used for detecting recent use of drugs such as
marijuana, with reported sensitivity of 86–90% and spe-
cificity of 75–77% (Bosker & Huestis 2009; Desrosiers et
al. 2012).
Conclusions
Alcohol and marijuana are each associated with
heightened risk of fatal crash involvement. When al-
cohol and marijuana are used together, there exists a
positive synergistic effect on the risk of fatal crash in-
volvement on the additive scale. These results suggest
that the combined effects of alcohol and marijuana
on fatal crash risk are significantly greater than the
sum of their separate effects. With the rising preva-
lence of marijuana use, potency, social tolerance,
early age of onset and availability, drug testing in
drivers should be strengthened and expanded and ef-
fective intervention programs to reduce DUID and its
adverse consequences should be implemented. Our
findings imply that countermeasures simultaneously
targeting alcohol-impaired driving and DUID might
be more effective in improving driving safety than in-
terventions targeting alcohol-impaired driving and
DUID in isolation. Epidemiologic research aimed at
quantifying the dose–response effect of marijuana on
crash risk is urgently needed.
Table 4 Estimated odds ratios and 95% confidence intervals of
fatal crash involvement according to driver BAC level stratified
by marijuana status in the continental United States, selected
time periods on Fridays and Saturdays, July 20 through
December 1, 2006, 2007 and 2008
Testing Result Marijuana Negative Marijuana Positive
BAC level aAdjusted OR 95% CI aAdjusted OR 95% CI
0 1.00 Reference 1.00 Reference
0.01–0.07 2.81 2.25, 3.51 1.81 0.93, 3.50
≥0.08 60.96 49.37, 75.25 82.12 41.73,161.61
BAC Blood Alcohol Content, g/dL, CI Confidence Interval OR Odds Ratio
aAdjusted for age, sex and region
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Appendix
Table 5 Estimated odds ratios and 95% confidence intervals of fatal crash involvement according to driver BAC level and marijuana
testing results in states that tested at least 80% of All fatally injured drivers, selected time periods on Fridays and Saturdays, July 20
through December 1, 2006, 2007 and 2008
Testing Result
Marijuana BAC level Crude OR 95% CI aAdjusted OR 95% CI
Negative 0 1.00 Reference 1.00 Reference
Positive 0 1.58 1.07, 2.35 1.76 1.17, 2.66
Negative 0.01-0.07 2.59 1.88, 3.55 2.66 1.91, 3.70
Positive 0.01-0.07 4.10 2.41, 6.96 4.69 2.69, 8.19
Negative ≥0.08 57.99 45.80, 73.43 58.33 44.91, 75.75
Positive ≥0.08 91.75 56.41, 149.22 102.94 61.13, 173.32
BAC Blood Alcohol Content, g/dL, CI Confidence Interval, OR Odds Ratio
aAdjusted for age, sex and region
Table 6 Estimated odds ratios and 95% confidence intervals of fatal crash involvement according to weighted driver BAC level and
marijuana testing results, selected time periods on Fridays and Saturdays, July 20 through December 1, 2006, 2007 and 2008
Testing Result
Marijuana BAC level Crude OR 95% CI aAdjusted OR 95% CI
Negative 0 1.00 Reference 1.00 Reference
Positive 0 1.44 1.03, 2.00 1.52 1.10, 2.08
Negative 0.01-0.07 2.80 2.12, 3.70 3.01 2.31, 3.93
Positive 0.01-0.07 4.02 2.57, 6.30 4.56 2.96, 7.04
Negative ≥0.08 63.57 45.05, 89.69 66.50 47.51, 93.08
Positive ≥0.08 91.34 55.26, 150.97 100.78 61.78, 164.37
BAC, Blood Alcohol Content, g/dL; CI, Confidence Interval; OR, Odds Ratio
aAdjusted for age, sex and region
Table 7 Estimated odds ratios and 95% confidence intervals of fatal crash involvement according to driver BAC level and
multiply imputed marijuana testing results, selected time periods on Fridays and Saturdays, July 20 through December 1, 2006,
2007 and 2008
Testing Result
Marijuana BAC level Crude OR 95% CI aAdjusted OR 95% CI
Negative 0 1.00 Reference 1.00 Reference
Positive 0 1.73 1.35, 2.21 1.84 1.43, 2.36
Negative 0.01-0.07 2.06 1.70, 2.50 2.34 1.90, 2.89
Positive 0.01-0.07 2.07 1.18, 3.62 2.49 1.40, 4.40
Negative ≥0.08 53.58 44.10, 65.11 60.43 49.37, 73.98
Positive ≥0.08 88.91 49.04, 161.18 101.93 56.70, 183.25
BAC Blood Alcohol Content, g/dL, CI Confidence Interval, OR Odds Ratio
aAdjusted for age, sex and region
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